[1] 翟红艳,王亚娇.趋化素、肿瘤坏死因子α与2型糖尿病视网膜病变的相关性[J].眼科新进展,2015,35(7):667-669. [2] Pan XR, Yang WY, Li GW, et al.Prevalence of diabetes and its risk factors in China[J]. Diabetes Care, 1997, 20(11):1664-1669. [3] Ghilardi G, Biondi ML, Erario M, et al.Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms[J].Clin Chem, 2003, 49(11):1940-1942. [4] Tuomainen AM, Kormi I, Havulinna AS, et al.Serum tissue-degrading proteinases and incident cardiovascular disease events J]. Eur J Prev Cardiol, 2014, 21(7): 806-812. [5] WHO. Report of the expert committee on diagnosis and classification of diabetics mellitus[J]. Diabetics Care, 2003, 26(suppl 1):s5-s20. [6] 中华医]学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南华医]学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南[J].中华眼科杂志,2014,50(11):851-865. [7] Miller SA, Dybes DD, Polesky HF.A simple salting out procedure for extracting DNA from human nucleated cells[J]. Nucleic Acid Res, 1988, 16(3): 1215. [8] Ye S.Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases[J]. Matrix Biol, 2000, 19(7): 623-629. [9] deVicente JC, Lequerica-Fernández P, Santamaría J, et al.Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis[J].J Oral Pathol Med, 2007, 36(7): 415-424. [10] Liu D, Nakano J, Ishikawa S, et al.Overexpression of matrix metalloproteinase-7(MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer[J]. Lung Cancer, 2007, 58(3): 384-391. [11] Yoshikawa T, Yanoma S, Tsuburaya A, et al.Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer[J]. Hepatogastroenterology, 2006, 53(72): 964-967. [12] Jomsjo S, Whatling C, Walter DH, et al.Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients[J]. Arterioscler Thromb Vasc Biol, 2001, 21(11): 1834-1839. |